Last reviewed · How we verify
NCT05380284: SDST
Senior Driving Simulation Training for Subjective Cognitive Decline and Mild Cognitive Impairment
NA trial testing Senior Driving Simulation Training in MCI in 90 participants. Completed in 28 May 2023.
1 January 2023
Quick facts
| Lead sponsor | Taipei Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 90 |
| Start date | 28 June 2022 |
| Primary completion | 1 January 2023 |
| Estimated completion | 28 May 2023 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Senior Driving Simulation Training
- Waiting list control
Conditions studied
- MCI — all drugs for MCI →
- Subjective Cognitive Decline — all drugs for Subjective Cognitive Decline →
- Healthy Aging — all drugs for Healthy Aging →
Sponsor
Taipei Medical University
Who can join
60 and older, any sex, with MCI or Subjective Cognitive Decline. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to establish the Senior Driving Simulation Training (SDST) for Subjective Cognitive Decline (SCD) and Mild Cognitive Impairment (MCI), and explore the effectiveness of Senior Driving Simulation Training (SDST) on the executive function, cognitive function and EEG.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05380284
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for MCI
Currently open trials in the same condition.
- NCT07499570 — Multi-modal Large Language Model-Empowered Talk Therapy for Older Adults With ADRD · NA · recruiting
- NCT06999434 — Exploring the Utility of [18F]3F4AP for Demyelination Imaging · Phase 1 · recruiting
- NCT06962501 — Acute Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity · NA · recruiting
- NCT07235111 — Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases · recruiting
- NCT07244770 — The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients · recruiting
Other Taipei Medical University trials
Trials by the same sponsor.
- NCT07496658 — Nutritional Status, Nutritional Knowledge and Mental Health Among Indonesian Migrant Workers in Taiwan · not yet recruiting
- NCT06930313 — Compassion-Based Intervention for Lung Cancer Caregivers (CBI-LCC) · NA · not yet recruiting
- NCT07349446 — Effects of Circadian-Based Acupressure on Sleep Quality in Nursing Home Residents · NA · not yet recruiting
- NCT07259369 — The Effects of an App-based Acupressure on Alleviating Fatigue, Pruritus, and Sleep Quality Among Hemodialysis Patients · NA · not yet recruiting
- NCT07275372 — Using Virtual Humans to Teach Cognitive Function Assessment to Nursing Students · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05380284 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Taipei Medical University
- Last refreshed: 1 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05380284.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing